---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-006213"
form_type: "8-K"
ticker: "ELTP"
cik: "0001053369"
company_name: "ELITE PHARMACEUTICALS INC /NV/"
filed_at: "2026-02-11T23:59:59+00:00"
generated_at: "2026-05-16T03:12:42.132063+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Elite Pharmaceuticals to release Q3 FY2026 results Feb 17, host call Feb 18

## Summary
- Q3 FY2026 financial results will be released on Tuesday, February 17, 2026.
- Conference call on Wednesday, February 18, 2026 at 11:30 AM EST.
- Dial-in: 1-800-346-7359 (domestic), 1-973-528-0008 (international), conference code 98840.
- Stockholders may submit general questions by 5 PM EST Feb 16; financial questions by 7 PM EST Feb 17.
- Questions can be emailed to dianne@elitepharma.com.

## SEC filing metadata
- accession: 0001493152-26-006213
- form_type: 8-K
- ticker: ELTP
- cik: 0001053369
- company_name: ELITE PHARMACEUTICALS INC /NV/
- filed_at: 2026-02-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 7.01, 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053369/000149315226006213/0001493152-26-006213-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053369/000149315226006213/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-006213
- JSON: https://secwatch.observer/filing/0001493152-26-006213.json
- Plain text: https://secwatch.observer/filing/0001493152-26-006213.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.